Quality measures in gynecologic cancers: What and when?

Gynecologic Oncology

Volumn 110, Issue 1, 2008, Pages 3-4

  Goff, Barbara A ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; DISEASE CLASSIFICATION; EDITORIAL; ENDOMETRIUM CANCER; GYNECOLOGIC CANCER; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE QUALITY; MEDICAID; MEDICAL SPECIALIST; MEDICARE; OUTCOME ASSESSMENT; OVARY CANCER; PRIORITY JOURNAL; VACCINATION;

DELIVERY OF HEALTH CARE; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; MEDICAID; MEDICARE; QUALITY ASSURANCE, HEALTH CARE; SPECIALTIES, MEDICAL; UNITED STATES;

EID: 45449108037     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.05.021     Document Type: Editorial

References (10)

1. Centers for Medicare and Medicaid 2008, PQTI Overview. http://www.cms.hhs.gov/pqri/
2. B. Bagley. Measuring for Medicare: The Physician Quality Reporting Initiative. Family Practice Management. http://www.aafp.org/fpm/20070600/37meas.html
3. Stulberg J. The Physician Quality Reporting Initiative-A gateway to pay for performance: what every health care professional should know. Q Manage Health Care 17 1 (2008) 208
4. Earle C.C., Schrag D., Neville B.A., Yabroff K.R., Topor M., Fahey A., et al. Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients. J Natl Cancer Inst 98 3 (2006) 172-180
5. Bristow R.E., Tomacruz R.S., Armstrong D.K., Trimble E.L., and Montz F.J. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 20 5 (2002) 1248-1259
6. National Cancer Institute, NCI clinical announcement, United State Department of Health and Human Services, Public Health Service, National Institutes of Health, Bethesda, MD (1999).
7. Bergstrom R., Sparen P., and Adami H.O. Trends in cancer of the cervix uteri in Sweden following cytological screening. Br J Cancer 81 1 (1999) 159-166
8. Janerich D.T., Hadjimichael O., Schwartz P.E., Lowell D.M., Meigs J.W., Merino M.J., et al. The screening histories of women with invasive cervical cancer, Connecticut. Am J Public Health 85 6 (1995) 791-794
9. Garland S.M., Hernandez-Avilla M., Sheeler C.M., Perez G., Harper D.M., Leodolter S., et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 356 19 (2007) 1928-1943
10. Cohn D.E., Huh W.K., Fowler J.M., and Straughn Jr. J.M. Cost-effectiveness analysis of strategies for the surgical management of grade 1 endometrial adenocarcinoma. Obstet Gynecol 109 6 (2007) 1388-1395